ijms-logo

Journal Browser

Journal Browser

Recent Advances of Proteomics in Human Health and Disease

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Informatics".

Deadline for manuscript submissions: 20 February 2025 | Viewed by 5852

Special Issue Editor


E-Mail Website
Guest Editor
Institute of Biomedical Chemistry, 119121 Moscow, Russia
Interests: human proteome; proteoforms; interactomics; bioinformatics

Special Issue Information

Dear Colleagues,

With the accumulation of omics data, the request for a healthy molecular profile of a person is increasingly emerging. As the final chord in the realization of genomic information, the proteome reflects the complete picture of molecular processes in the body. Nevertheless, despite the significant and encouraging progress in developing proteomic technologies, there are still many difficulties with a complete inventory of all molecules. Low-copy proteins, as well as aberrant forms, are still difficult to detect. This limitation complicates the decoding of biological processes and further identification of predictive, diagnostic, and therapeutic biomarkers of diseases.

This Special Issue focuses on (but is not limited to) the application of proteomics solo and in integration with other omics in disease, with emphasis on biomarkers, molecular mechanisms of disease, new drug targets, aberrant proteoforms, proteins functional annotation, proteomic studies on the disease model or patient cohort studies, and novel proteomics methodologies and strategies.

Dr. Ekaterina Poverennaya
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • proteomics
  • biomarkers
  • drug target
  • disease mechanism
  • signalling pathways
  • interactomics
  • omics
  • proteoforms
  • bioinformatics
  • technology development

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers (4 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Research

Jump to: Review

16 pages, 3000 KiB  
Article
IQGAP3 Is an Important Mediator of Skin Inflammatory Diseases
by Alena Zolotarenko and Sergey Bruskin
Int. J. Mol. Sci. 2024, 25(8), 4545; https://doi.org/10.3390/ijms25084545 - 21 Apr 2024
Viewed by 1383
Abstract
IQGAP3 (IQ Motif Containing GTPase Activating Protein 3) is member of the IQGAP family of scaffold proteins, which are essential for assembling multiprotein complexes that coordinate various intracellular signaling pathways. Previous research has shown that IQGAP3 is overexpressed in psoriatic skin lesions. Given [...] Read more.
IQGAP3 (IQ Motif Containing GTPase Activating Protein 3) is member of the IQGAP family of scaffold proteins, which are essential for assembling multiprotein complexes that coordinate various intracellular signaling pathways. Previous research has shown that IQGAP3 is overexpressed in psoriatic skin lesions. Given its involvement in processes like cell proliferation and chemokine signaling, we sought to explore its molecular role in driving the psoriatic phenotype of keratinocytes. By conducting transcriptome profiling of HaCaT keratinocytes, we identified numerous psoriasis-associated pathways that were affected when IQGAP3 was knocked down. These included alterations in NFkB signaling, EGFR signaling, activation of p38/MAPK and ERK1/ERK2, lipid metabolism, cytokine production, and the response to inflammatory cytokine stimulation. Real-time analysis further revealed changes in cell growth dynamics, including proliferation and wound healing. The balance between cell proliferation and apoptosis was altered, as were skin barrier functions and the production of IL-6 and IFNγ. Despite these significant findings, the diversity of the alterations observed in the knockdown cells led us to conclude that IQGAP3 may not be the best target for the therapeutic inhibition to normalize the phenotype of keratinocytes in psoriasis. Full article
(This article belongs to the Special Issue Recent Advances of Proteomics in Human Health and Disease)
Show Figures

Figure 1

23 pages, 8253 KiB  
Article
Exploring the Molecular Tapestry: Organ-Specific Peptide and Protein Ultrafiltrates and Their Role in Therapeutics
by Jakub Peter Slivka, Chris Bauer, Alexander Younsi, Michelle B. F. Wong, Mike K. S. Chan and Thomas Skutella
Int. J. Mol. Sci. 2024, 25(5), 2863; https://doi.org/10.3390/ijms25052863 - 1 Mar 2024
Viewed by 1567
Abstract
This study aims to characterize the proteome composition of organ-derived protein extracts from rabbits. Protein isolation was performed using soft homogenization and size exclusion via ultrafiltration. The proteome analysis of the ultrafiltrates was conducted using gel electrophoresis, and the mass spectrometry data were [...] Read more.
This study aims to characterize the proteome composition of organ-derived protein extracts from rabbits. Protein isolation was performed using soft homogenization and size exclusion via ultrafiltration. The proteome analysis of the ultrafiltrates was conducted using gel electrophoresis, and the mass spectrometry data were subjected to gene ontology analysis. Proteomic profiling revealed comprehensive protein profiles associated with RNA regulation, fatty acid binding, inflammatory response, oxidative stress, and metabolism. Additionally, our results demonstrate the presence of abundant small proteins, as observed in the mass spectrometry datasets. Small proteins and peptides are crucial in transcription modulation and various biological processes. The protein networks identified in the ultrafiltrates have the potential to enhance and complement biological therapeutic interventions. Data are available via ProteomeXchange with identifier PXD050039. Full article
(This article belongs to the Special Issue Recent Advances of Proteomics in Human Health and Disease)
Show Figures

Figure 1

Review

Jump to: Research

13 pages, 1408 KiB  
Review
Proteomic Markers of Aging and Longevity: A Systematic Review
by Anna A. Kliuchnikova, Ekaterina V. Ilgisonis, Alexander I. Archakov, Elena A. Ponomarenko and Alexey A. Moskalev
Int. J. Mol. Sci. 2024, 25(23), 12634; https://doi.org/10.3390/ijms252312634 - 25 Nov 2024
Viewed by 349
Abstract
This article provides a systematic review of research conducted on the proteomic composition of blood as part of a complex biological age estimation. We performed a comprehensive analysis of 17 publicly available datasets and compiled an integral list of proteins. These proteins were [...] Read more.
This article provides a systematic review of research conducted on the proteomic composition of blood as part of a complex biological age estimation. We performed a comprehensive analysis of 17 publicly available datasets and compiled an integral list of proteins. These proteins were sorted based on their detection probability using mass spectrometry in human plasma. We propose this list as a basis for creating a panel of peptides and quantifying the content of selected proteins in the format of a proteomic aging clock. The selected proteins are especially notable for their roles in inflammatory processes and lipid metabolism. Our findings suggest, for the first time, that proteins associated with systemic disorders, including those approved by the FDA for clinical use, could serve as potential markers of aging. Full article
(This article belongs to the Special Issue Recent Advances of Proteomics in Human Health and Disease)
Show Figures

Figure 1

17 pages, 1363 KiB  
Review
Low-Abundance Protein Enrichment for Medical Applications: The Involvement of Combinatorial Peptide Library Technique
by Egisto Boschetti and Pier Giorgio Righetti
Int. J. Mol. Sci. 2023, 24(12), 10329; https://doi.org/10.3390/ijms241210329 - 19 Jun 2023
Cited by 5 | Viewed by 1997
Abstract
The discovery of low- and very low-abundance proteins in medical applications is considered a key success factor in various important domains. To reach this category of proteins, it is essential to adopt procedures consisting of the selective enrichment of species that are present [...] Read more.
The discovery of low- and very low-abundance proteins in medical applications is considered a key success factor in various important domains. To reach this category of proteins, it is essential to adopt procedures consisting of the selective enrichment of species that are present at extremely low concentrations. In the past few years pathways towards this objective have been proposed. In this review, a general landscape of the enrichment technology situation is made first with the presentation and the use of combinatorial peptide libraries. Then, a description of this peculiar technology for the identification of early-stage biomarkers for well-known pathologies with concrete examples is given. In another field of medical applications, the determination of host cell protein traces potentially present in recombinant therapeutic proteins, such as antibodies, is discussed along with their potentially deleterious effects on the health of patients on the one hand, and on the stability of these biodrugs on the other hand. Various additional applications of medical interest are disclosed for biological fluids investigations where the target proteins are present at very low concentrations (e.g., protein allergens). Full article
(This article belongs to the Special Issue Recent Advances of Proteomics in Human Health and Disease)
Show Figures

Figure 1

Back to TopTop